started · updated
Italy launches AI periodic table of mutations for oncology
A new digital platform called the ‘Periodic Table of Mutations’ has been launched in Italy to assist in the management, classification, and visualization of gene variants in oncology. The platform aims to facilitate the interpretation of molecular alterations and support clinical decision-making using the best available scientific evidence.
The project was developed by the Molecular Pathology and Precision Medicine Group (Pmmp) of Siapec, in collaboration with the Italian Association of Medical Oncology (Aiom) and the Atlas Italia Foundation. It received non-conditional contributions from AstraZeneca and Thermo Fisher Scientific.
Utilizing artificial intelligence, the system processes gene variants identified through laboratory analysis to generate a specific metric known as the Pmmp Score. This score synthesizes clinical research data to help oncologists and pathologists determine the level of scientific evidence associated with a mutation and the likelihood of a patient responding to specific therapies. The platform was presented during the 28th Aiom National Congress in Rome.
Entities
Associazione Italiana di Oncologia Medica · AstraZeneca · Rome · Siapec · Thermo Fisher Scientific
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 4 SOURCES] A new digital platform called the ‘Periodic Table of Mutations’ has been launched in Italy for managing oncological gene variants. www.lsdmagazine.com · www.senzalinea.it · www.ilfattonisseno.it · quotidianodifoggia.it
- [● 4 SOURCES] The platform uses artificial intelligence to generate a specific score called the Pmmp Score. www.lsdmagazine.com · www.senzalinea.it · www.ilfattonisseno.it · quotidianodifoggia.it
- [● 4 SOURCES] The platform was developed by the Pmmp group of Siapec, Aiom, and the Atlas Italia Foundation. www.lsdmagazine.com · www.senzalinea.it · www.ilfattonisseno.it · quotidianodifoggia.it
- [● 4 SOURCES] The platform was presented during the 28th Aiom National Congress in Rome. www.lsdmagazine.com · www.senzalinea.it · www.ilfattonisseno.it · quotidianodifoggia.it
- [● 4 SOURCES] AstraZeneca and Thermo Fisher Scientific provided non-conditional contributions to the project. www.lsdmagazine.com · www.senzalinea.it · www.ilfattonisseno.it · quotidianodifoggia.it